Aventis Pharma to expand its bulk drug unit at Ankleshwar in Bharuch district in Gujarat with an investment of Rs. 890 million. The new unit will manufacture the following products
|
Sl. No |
Name of product |
- |
Existing Capacity (TPA) |
Proposed Capacity (TPA) |
Total Capacity (TPA) |
|
1. |
Pentoxifylline |
Bulk drug |
44 |
206 |
250 |
|
2. |
Phenaramine Maleate |
Bulk drug |
72 |
38 |
100 |
|
3. |
Frusemide |
Bulk drug |
60 |
80 |
140 |
|
4. |
Ciclopiroxlamine |
Bulk drug |
0.167 |
-0.167 |
0 |
|
5. |
Glibenclamide |
Bulk drug |
11 |
14 |
25 |
|
6. |
Ramipril Substance |
Bulk drug |
0.3 |
-0.3 |
0 |
|
7. |
Tonophosphan |
Bulk drug |
1 |
-1 |
0 |
|
8. |
Articaine HCl |
Bulk drug |
22 |
8 |
30 |
|
9. |
ACME (RP II 3) |
Intermediate |
28 |
7 |
35 |
|
10. |
Phenoxypiretan |
Intermediate |
2 |
8 |
10 |
|
11. |
Hydrochlorothiazide |
Bulk drug |
5 |
35 |
40 |
|
12. |
Ketoprofen |
Bulk drug |
2 |
13 |
15 |
|
13. |
ABAP |
Intermediate |
5 |
75 |
80 |
|
14. |
Acebutolol |
Bulk drug |
0 |
25 |
25 |
|
15. |
Buprenorphine HCl |
Bulk drug |
0 |
0.5 |
0.5 |
|
16. |
TDPA |
Intermediate |
0 |
40 |
40 |
|
17. |
TOTAL (Ton per annum) |
Bulk drug & intermediate |
252 |
538 |
791 |
|
18. |
Pharma Formulations (Solid) mio tablets/annum |
|
5577 |
0 |
5577 |
The company has proposed for change in product mix for future details are as given below:
|
Sl. No. |
Name of product |
Capacity TPA |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
|
1. |
Pentoxifylline |
250 |
44 |
44 |
100 |
150 |
200 |
250 |
|
2. |
Phenaramine Maleate |
100 |
72 |
72 |
85 |
100 |
100 |
100 |
|
3. |
Frusemide |
140 |
60 |
60 |
100 |
140 |
140 |
140 |
|
4. |
Ciclopiroxlamine |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
5. |
Glibenclamide |
25 |
11 |
11 |
15 |
20 |
25 |
25 |
|
6. |
Ramipril Substance |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
7. |
Tonophosphan |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
8. |
Articaine |
30 |
22 |
22 |
25 |
30 |
30 |
30 |
|
9. |
ACME (RP II 3) |
35 |
28 |
28 |
30 |
30 |
35 |
35 |
|
10. |
Phenoxypiretan |
10 |
2 |
2 |
4 |
6 |
8 |
10 |
|
11. |
Hydrochlorothiazide |
40 |
5 |
5 |
15 |
30 |
40 |
40 |
|
12. |
Ketoprofen |
15 |
2 |
2 |
2 |
5 |
10 |
15 |
|
13. |
ABAP |
80 |
5 |
5 |
10 |
10 |
50 |
80 |
|
14. |
Acebutolol |
25 |
0 |
0 |
5 |
10 |
20 |
25 |
|
15. |
Buprenorphine |
0.5 |
0 |
0 |
0 |
0.2 |
0.4 |
0.5 |
|
16. |
TDPA |
40 |
0 |
0 |
0 |
10 |
20 |
40 |
|
17. |
TOTAL (Ton per annum) |
791 |
251 |
251 |
391 |
541 |
678 |
791 |
|
18. |
Pharma Formulation(Solid) mio tablets/annum |
5577 |
5577 |
5577 |
5577 |
5577 |
5577 |
5577 |
|
|
|
|
|
|
| 11,950 ₹ | 4950 ₹ | 4950 ₹ | 4950 ₹ | 3950 ₹ |
Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202 Mobile : 0-97898-37940 email : [email protected] Privacy Policy
